IL138681A0 - Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b - Google Patents
Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup bInfo
- Publication number
- IL138681A0 IL138681A0 IL13868199A IL13868199A IL138681A0 IL 138681 A0 IL138681 A0 IL 138681A0 IL 13868199 A IL13868199 A IL 13868199A IL 13868199 A IL13868199 A IL 13868199A IL 138681 A0 IL138681 A0 IL 138681A0
- Authority
- IL
- Israel
- Prior art keywords
- attenuation
- respiratory syncytial
- virus
- human respiratory
- subgroup
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7946698P | 1998-03-26 | 1998-03-26 | |
PCT/US1999/006225 WO1999049017A2 (en) | 1998-03-26 | 1999-03-22 | Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b |
Publications (1)
Publication Number | Publication Date |
---|---|
IL138681A0 true IL138681A0 (en) | 2001-10-31 |
Family
ID=22150746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13868199A IL138681A0 (en) | 1998-03-26 | 1999-03-22 | Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1064358A2 (xx) |
JP (1) | JP2002507408A (xx) |
KR (1) | KR20010080863A (xx) |
CN (2) | CN1600852A (xx) |
AU (1) | AU767193B2 (xx) |
BR (1) | BR9909076A (xx) |
CA (1) | CA2323927A1 (xx) |
IL (1) | IL138681A0 (xx) |
WO (1) | WO1999049017A2 (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60124098T2 (de) * | 2000-06-23 | 2007-04-05 | Wyeth Holdings Corp. | Modifiziertes Morbillivirus V Proteine |
DE60233038D1 (de) * | 2002-06-20 | 2009-09-03 | Pasteur Institut | Infektiöse cDNA eines zugelassenen Impfstammes des Masern Virus. Verwendung in immunogenen Zusammensetzungen |
AU2004226369A1 (en) * | 2003-03-28 | 2004-10-14 | Medimmune, Llc | Compositions and methods involving respiratory syncytial virus subgroup B strain 9320 |
JPWO2008065752A1 (ja) * | 2006-11-30 | 2010-03-04 | 国立大学法人北海道大学 | diRNAを有効成分とする免疫治療用薬剤 |
WO2010053883A1 (en) | 2008-11-05 | 2010-05-14 | Merck Sharp & Dohme Corp. | Live, attentuated respiratory syncytial virus |
EP2420242A1 (en) | 2010-08-20 | 2012-02-22 | Lauer, Ulrich M. | Oncolytic measles virus |
JP6453063B2 (ja) * | 2014-12-02 | 2019-01-16 | 国立大学法人北海道大学 | アジュバント組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3045581B2 (ja) * | 1991-10-14 | 2000-05-29 | 社団法人北里研究所 | 麻疹ワクチンウイルス株同定方法 |
TW275632B (xx) * | 1992-04-21 | 1996-05-11 | American Cyanamid Co | |
KR20000048628A (ko) * | 1996-09-27 | 2000-07-25 | 윌리암 에이취 캘넌, 에곤 이 버그 | 모노네가비랄레스 목의 바이러스에서 감쇠를 책임지는 3' 게놈프로모터 영역 및 폴리머라제 유전자 돌연변이 |
-
1999
- 1999-03-22 AU AU31095/99A patent/AU767193B2/en not_active Ceased
- 1999-03-22 BR BR9909076-7A patent/BR9909076A/pt not_active IP Right Cessation
- 1999-03-22 WO PCT/US1999/006225 patent/WO1999049017A2/en not_active Application Discontinuation
- 1999-03-22 JP JP2000537978A patent/JP2002507408A/ja active Pending
- 1999-03-22 CN CNA2004100685486A patent/CN1600852A/zh active Pending
- 1999-03-22 CA CA002323927A patent/CA2323927A1/en not_active Abandoned
- 1999-03-22 IL IL13868199A patent/IL138681A0/xx unknown
- 1999-03-22 CN CNB998043826A patent/CN1177927C/zh not_active Expired - Fee Related
- 1999-03-22 KR KR1020007010624A patent/KR20010080863A/ko not_active Application Discontinuation
- 1999-03-22 EP EP99912799A patent/EP1064358A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2002507408A (ja) | 2002-03-12 |
WO1999049017A3 (en) | 1999-12-16 |
AU767193B2 (en) | 2003-11-06 |
CN1177927C (zh) | 2004-12-01 |
EP1064358A2 (en) | 2001-01-03 |
CN1294628A (zh) | 2001-05-09 |
CA2323927A1 (en) | 1999-09-30 |
WO1999049017A2 (en) | 1999-09-30 |
KR20010080863A (ko) | 2001-08-25 |
BR9909076A (pt) | 2000-12-05 |
AU3109599A (en) | 1999-10-18 |
CN1600852A (zh) | 2005-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG24026A (en) | Respiratory syncytial virus replication inhibitors | |
HUP0201869A3 (en) | Respiratory syncytial virus replication inhibitors | |
HK1045998B (zh) | 呼吸道合胞病毒複製抑制劑 | |
EP1112091A4 (en) | FAST DEEP TEMPERATURE PRESSURE STERILIZATION AND VACCINE PRODUCTION | |
HK1042084B (zh) | 取代的苯並咪唑及其製備和用途 | |
AP2001002366A0 (en) | Systems and methods for aerosolizing pharmacetical formulations | |
IL139279A0 (en) | Disposable pant-type diaper having improved protection against red marking and method for making the same | |
HU9900163D0 (en) | Sterol and stanol-esters, preparation and use thereof | |
IL141562A0 (en) | Particulate compositions for pulmonary delivery and methods for the preparation thereof | |
IL138609A0 (en) | Antipicornaviral compounds, their preparation and use | |
HUP0102585A2 (hu) | Tienil-azolilalkoxietánamin-származékok, ezek előállítása és gyógyszerkénti alkalmazásuk | |
GB9810054D0 (en) | Smoking substance for use in therapy | |
EP0975363A4 (en) | MITIGATED RESPIRATORY SYNCYTIAL VIRUS | |
IL138681A0 (en) | Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b | |
ATE276234T1 (de) | Harnstoffderivate zur schmerzbekämpfung | |
AU2000277264A1 (en) | Heat-moisture exchanger and nebulization device | |
AU6200399A (en) | Avian pneumovirus vaccine and diagnostic agent | |
HUP0102409A3 (en) | Pyrimidin-aminomethhyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria | |
EP0917592A4 (en) | REDUCED RSV | |
GB9808278D0 (en) | Face mask for ventilated patient | |
HUP0203771A3 (en) | Disinfectant agent concentrate and its use | |
EP1096889A4 (en) | HOSE DEVICE FOR CLEAN BREATH | |
IL137076A0 (en) | Bibapctitide-based pharmaceutical compositions for imaging and treating thrombi | |
LT98110A (en) | Polytetra-ammonium salt, method for preparation and use thereof | |
HK1006915A2 (en) | Vertebras orthopaedic net-support |